Cresset Asset Management, LLC Dexcom Inc Transaction History

Cresset Asset Management, LLC

$25.6 Billion
Q3 2024

A detailed history of Cresset Asset Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cresset Asset Management, LLC holds 44,829 shares of DXCM stock, worth $3.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,829

Previous 53,457 16.14%

Holding current value

$3.37 Million

Previous $6.06 Million 50.43%

% of portfolio

0.01%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $552,192 - $1 Million	-8,628 Reduced 16.14%	44,829 $3 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $149,470 - $190,309	1,355 Added 2.6%	53,457 $6.06 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1.58 Million - $1.94 Million	13,876 Added 36.3%	52,102 $7.23 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $14,645 - $24,087	194 Added 0.51%	38,226 $4.74 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $55,336 - $88,688	-643 Reduced 1.66%	38,032 $3.55 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $3.6 Million - $4.19 Million	32,002 Added 479.57%	38,675 $4.97 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $186,472 - $220,395	-1,793 Reduced 21.18%	6,673 $775,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $8,752 - $12,635	-103 Reduced 1.2%	8,466 $958,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $20,614 - $25,428	-270 Reduced 3.05%	8,569 $690,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $366,874 - $717,074	5,396 Added 156.72%	8,839 $659,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $55,695 - $77,078	592 Added 20.76%	3,443 $1.76 Million
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $99,220 - $124,394	764 Added 36.61%	2,851 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $173,190 - $232,381	-1,623 Reduced 43.75%	2,087 $1.14 Million
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $244,913 - $326,380	3,024 Added 440.82%	3,710 $1.58 Million
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $9,920 - $12,254	117 Added 20.56%	686 $247,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $7,098 - $9,509	-91 Reduced 13.79%	569 $210,000
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $6,876 - $8,132	72 Added 12.24%	660 $272,000
Q2 2020 Aug 04, 2020	BUY	$62.68 - $105.34 $36,855 - $61,939	588 New	588 $238,000
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $48,775 - $68,187	-1,752 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $46,006 - $62,577	1,639 Added 1450.44%	1,752 $209,000
Q4 2018 May 21, 2019	BUY	$26.99 - $37.37 $3,049 - $4,222	113 New	113 $14,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Dexcom Inc Transaction History